Coldstream Capital Management Inc Biotechnology

Coldstream Capital Management Inc

$4.64 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
DSGN Design Therapeutics, Inc.	$223M	$2,000 0.0% of portfolio	535	Q1 2025 New
TERN Terns Pharmaceuticals, Inc.	$134M	$2,000 0.0% of portfolio	998	Q1 2025 New
ASND Ascendis Pharma A/S	$9.66B	$2,000 0.0% of portfolio	18	Q1 2025 New
ARVN Arvinas, Inc.	$417M	$1,000 0.0% of portfolio	157	Q1 2025 New
CDXS Codexis, Inc.	$148M	$1,000 0.0% of portfolio	435	Q1 2025 New
DNLI Denali Therapeutics Inc.	$1.96B	$1,000 0.0% of portfolio	145	Q1 2025 New
EDIT Editas Medicine, Inc.	$124M	$1,000 0.0% of portfolio	1,582	Q1 2025 New
NVAX Novavax Inc	$580M	$1,000 0.0% of portfolio	266	Q1 2025 New
NRIX Nurix Therapeutics, Inc.	$589M	$1,000 0.0% of portfolio	117	Q1 2025 New
PGEN Precigen, Inc.	$308M	$1,000 0.0% of portfolio	827	Q1 2025 New
RYTM Rhythm Pharmaceuticals, Inc.	$3.66B	$1,000 0.0% of portfolio	30	Q1 2025 New
DAWN Day One Biopharmaceuticals, Inc.	$511M	$1,000 0.0% of portfolio	205	Q1 2025 New
NAUT Nautilus Biotechnology, Inc.	$92.3M	$1,000 0.0% of portfolio	1,412	Q1 2025 New
CMRX Chimerix Inc	$748M	$1,000 0.0% of portfolio	223	Q1 2025 New
VRDN Viridian Therapeutics, Inc.\De	$579M	$1,000 0.0% of portfolio	134	Q1 2025 New
ANTX An2 Therapeutics, Inc.	$21.3M	$1,000 0.0% of portfolio	783	Q1 2025 New
TNGX Tango Therapeutics, Inc.	$309M	$1,000 0.0% of portfolio	969	Q1 2025 New
GLUE Monte Rosa Therapeutics, Inc.	$216M	$1,000 0.0% of portfolio	355	Q1 2025 New
CMPX Compass Therapeutics, Inc.	$254M	$1,000 0.0% of portfolio	879	Q1 2025 New
ELYM Eliem Therapeutics, Inc.	$109M	$1,000 0.0% of portfolio	336	Q1 2025 New
CGEM Cullinan Oncology, Inc.	$399M	$1,000 0.0% of portfolio	207	Q1 2025 New
INMB Inmune Bio, Inc.	$138M	$1,000 0.0% of portfolio	145	Q1 2025 New
TSVT 2seventy Bio, Inc.	$189M	$0 0.0% of portfolio	172	Q1 2025 New
AVTE Aerovate Therapeutics, Inc.	$65.5M	$0 0.0% of portfolio	104	Q1 2025 New
ALLO Allogene Therapeutics, Inc.	$203M	$0 0.0% of portfolio	205	Q1 2025 New
ABUS Arbutus Biopharma Corp	$517M	$0 0.0% of portfolio	284	Q1 2025 New
ATHA Athira Pharma, Inc.	$11.7M	$0 0.0% of portfolio	2,640	Q1 2025 New
CABA Cabaletta Bio, Inc.	$63.3M	$0 0.0% of portfolio	280	Q1 2025 New
CELC Celcuity Inc.	$196M	$0 0.0% of portfolio	53	Q1 2025 New
CHRS Coherus Bio Sciences, Inc.	$63M	$0 0.0% of portfolio	850	Q1 2025 New
FATE Fate Therapeutics Inc	$147M	$0 0.0% of portfolio	686	Q1 2025 New
FGEN Fibrogen Inc	$29.1M	$0 0.0% of portfolio	1,073	Q1 2025 New
MGNX Macrogenics Inc	$107M	$0 0.0% of portfolio	503	Q1 2025 New
MNKD Mannkind Corp	$1.11B	$0 0.0% of portfolio	24	Q1 2025 New
ORIC Oric Pharmaceuticals, Inc.	$388M	$0 0.0% of portfolio	45	Q1 2025 New
PRTA Prothena Corp Public LTD CO	$247M	$0 0.0% of portfolio	51	Q1 2025 New
PBYI Puma Biotechnology, Inc.	$154M	$0 0.0% of portfolio	304	Q1 2025 New
RGNX Regenxbio Inc.	$361M	$0 0.0% of portfolio	81	Q1 2025 New
RLAY Relay Therapeutics, Inc.	$420M	$0 0.0% of portfolio	341	Q1 2025 New
STTK Shattuck Labs, Inc.	$48.3M	$0 0.0% of portfolio	321	Q1 2025 New
TARS Tarsus Pharmaceuticals, Inc.	$1.2B	$0 0.0% of portfolio	12	Q1 2025 New
TSHA Taysha Gene Therapies, Inc.	$140M	$0 0.0% of portfolio	207	Q1 2025 New
URGN Uro Gen Pharma Ltd.	$131M	$0 0.0% of portfolio	29	Q1 2025 New
VERA Vera Therapeutics, Inc.	$567M	$0 0.0% of portfolio	6	Q1 2025 New
VIR Vir Biotechnology, Inc.	$720M	$0 0.0% of portfolio	89	Q1 2025 New
SAVA Cassava Sciences Inc	$85M	$0 0.0% of portfolio	291	Q1 2025 New
KALV Kal Vista Pharmaceuticals, Inc.	$345M	$0 0.0% of portfolio	69	Q1 2025 New
PHAT Phathom Pharmaceuticals, Inc.	$186M	$0 0.0% of portfolio	109	Q1 2025 New
STOK Stoke Therapeutics, Inc.	$429M	$0 0.0% of portfolio	55	Q1 2025 New
ABOS Acumen Pharmaceuticals, Inc.	$44.1M	$0 0.0% of portfolio	311	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.